About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,554 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,554 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1981-2000 of 7,554 trials

CompletedStudy of Dose Escalation of Abiraterone Actetate in Prostate CancerThe purpose of this study is to test whether a dose escalation up to 2000 mg per day of abiraterone acetate is feasible and lead to disease stabilization in castration-resistant…NCT03458247·Paris, Paris TerminatedQuantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate CancerWith Contrast Enhanced UltraSound (CEUS) cancer induced neovascularisation can be visualised with the potential to improve ultrasound imaging for prostate cancer detection and…NCT01481441·Amsterdam CompletedBiomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen TherapyThis is an open label phase II, single-arm, biomarker multi-institutional pilot study.NCT04424654·Porto Alegre, Rio Grande do Sul and 1 other

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedCu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate CancerThis is a prospective, open-label Phase 2 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent metastatic prostate cancer after radical…NCT05653856·New Haven, Connecticut and 8 others

CompletedEarly Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Docetaxel and cabazitaxel are cancer chemotherapy agents of the taxane drug class.NCT01718353·Birmingham, Alabama and 18 others

TerminatedExtension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsAn Open-Label, Multi-Center, Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsNCT00215657

TerminatedCalcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone MetastasisRATIONALE: Diagnostic procedures, such as radionuclide imaging using calcium-41 (41Ca) chloride aqueous solution, may help predict progressive disease in patients with prostate…NCT00918645·Livermore, California

CompletedProstate Cancer Screening Trial Using ImagingParticipants will be recruited from the community and attend a screening clinic and undergo the following screening tests: 1.NCT03702439·London

SuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningThis is a Phase Ib Pilot study of anti-PSMA designer T cells in metastatic prostate cancer.NCT01929239·Providence, Rhode Island

Active not recruitingThe BARCODE 1 Pilot StudyBARCODE 1 is a screening study designed to investigate the role of genetic profiling for targeting population prostate cancer screening.NCT03158922·Sutton, Surrey

CompletedBehavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate CaTo refine a remote behavioral exercise training intervention for testing in a larger randomized trial.NCT06250751·Richmond, Virginia

RecruitingThe Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)Prostate cancer is the most common non-skin cancer among Veterans and the second leading cause of male cancer death.NCT05926102·Boston, Massachusetts

WithdrawnTesting the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to BonesThis phase I trial tests the safety, side effects and best dose of tin (Sn)-177m-diethylenetriaminepentaacetic acid (DTPA) and how well it works in treating prostate, breast or…NCT06982222

UnknownIncreasing Access to Definitive Treatment for Prostate CancerInvestigators will address the overarching challenge of advancing health equity and reducing disparities in prostate cancer by informing efforts to reduce travel burden in…NCT06034431·Boston, Massachusetts

CompletedImproving Quality of Life of Prostate Cancer Survivors With Androgen DeficiencyThe purpose of this phase II trial is to determine the efficacy and safety of testosterone replacement therapy (TRT) in improving the symptoms of androgen deficiency and…NCT03716739·Baltimore, Maryland and 2 others

RecruitingScreening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland.NCT06626022·Los Angeles, California and 8 others

WithdrawnMISOBOLD - Prostate Cancer Hypoxia Using BOLD MRI and 18F-MISO PET ImagingThis feasibility exploratory study objective is to assess the ability of combined MRI BOLD and 18F-MISO PET imaging to visualize tumor hypoxia compare to histological results…NCT03293602·Toulouse

CompletedA QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to determine the effect of abiraterone acetate plus prednisone on the conduction of electric charges within the heart and to determine the blood…NCT00910754·Buffalo, New York and 7 others

CompletedFocal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate LesionsThe hypothesis of this study is that focal treatment with ExAblate MRgFUS has the potential to be an effective non-invasive treatment for intermediate risk, organ-confined…NCT01657942·Duarte, California and 8 others

Active not recruitingPRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTsThe goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing…NCT06051942·La Mesa, California and 5 others

PreviousPage 100 of 378Next